Overcoming therapeutic inertia in primary care: a multisite quality initiative to increase guideline-based prescribing for patients with diabetes. [PDF]
BMJ Open QualLatreille MW, Tompkins BJ, Repp AB.
europepmc +1 more source
Evaluating the Rates of Pancreatitis and Pancreatic Cancer Among GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. [PDF]
Endocrinol Diabetes MetabWen J +9 more
europepmc +1 more source
Real-World Harm Reduction of Metformin Plus DPP4 Inhibitors versus Metformin Plus Sulfonylureas in Older Adults: A Target Trial Emulation Using German Claims Data. [PDF]
Drugs AgingStarke P +4 more
europepmc +1 more source
Exploring Combined Use of Continuous Glucose Monitoring and Anti-Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin. [PDF]
Endocrinol Diabetes MetabNemlekar PM +3 more
europepmc +1 more source
HNF1α-Q125ter-mediated mitochondrial dysfunction and impaired mitophagy in β-cells. [PDF]
J Mol EndocrinolJiang F +4 more
europepmc +1 more source
The impact of sulfonylureas on diverse ion channels: an alternative explanation for the antidiabetic actions. [PDF]
Front Cell Dev BiolLi XT, Yun MZ.
europepmc +1 more source
Gliclazide Challenge Testing as an Alternative Diagnostic Tool for Hepatocyte Nuclear Factor-1-Alpha Maturity Onset Diabetes of the Young. [PDF]
Eur J Case Rep Intern MedPandya S +6 more
europepmc +1 more source
Efficacy of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Moderate-to-Severe COPD Exacerbations Among Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. [PDF]
Pharmaceuticals (Basel)Pirera E +3 more
europepmc +1 more source